Journal of Stroke (Sep 2021)
Effectiveness of Thrombectomy in Stroke According to Baseline Prognostic Factors: Inverse Probability of Treatment Weighting Analysis of a Population-Based Registry
- Salvatore Rudilosso,
- José Ríos,
- Alejandro Rodríguez,
- Meritxell Gomis,
- Víctor Vera,
- Manuel Gómez-Choco,
- Arturo Renú,
- Núria Matos,
- Laura Llull,
- Francisco Purroy,
- Sergio Amaro,
- Mikel Terceño,
- Víctor Obach,
- Joaquim Serena,
- Joan Martí-Fàbregas,
- Pedro Cardona,
- Carlos Molina,
- Ana Rodríguez-Campello,
- David Cánovas,
- Jerzy Krupinski,
- Xavier Ustrell,
- Ferran Torres,
- Luis San Román,
- Mercè Salvat-Plana,
- Francesc Xavier Jiménez-Fàbrega,
- Ernest Palomeras,
- Esther Catena,
- Carla Colom,
- Dolores Cocho,
- Juanjo Baiges,
- Josep Maria Aragones,
- Gloria Diaz,
- Xavier Costa,
- María Cruz Almendros,
- Maria Rybyeba,
- Miquel Barceló,
- Dolors Carrión,
- Matilde Núria Lòpez,
- Eduard Sanjurjo,
- Natalia Pérez de la Ossa,
- Xabier Urra,
- Ángel Chamorro,
- for the Catalan Stroke Code and Reperfusion (Cat-SCR) Consortium
Affiliations
- Salvatore Rudilosso
- Comprehensive Stroke Center, Department of Neuroscience, Hospital Clínic of Barcelona, Barcelona, Spain
- José Ríos
- Medical Statistics Core Facility, August Pi i Sunyer Biomedical Research Institute (IDIBAPS) and Hospital Clinic, Barcelona, Spain
- Alejandro Rodríguez
- Comprehensive Stroke Center, Department of Neuroscience, Hospital Clínic of Barcelona, Barcelona, Spain
- Meritxell Gomis
- Stroke Unit, Department of Neuroscience, Germans Trias Hospital, Badalona, Spain
- Víctor Vera
- Comprehensive Stroke Center, Department of Neuroscience, Hospital Clínic of Barcelona, Barcelona, Spain
- Manuel Gómez-Choco
- Department of Neurology, Moisès-Broggi Hospital, Sant Joan Despí, Spain
- Arturo Renú
- Comprehensive Stroke Center, Department of Neuroscience, Hospital Clínic of Barcelona, Barcelona, Spain
- Núria Matos
- Department of Neurology, Althaia Foundation Hospital, Manresa, Spain
- Laura Llull
- Comprehensive Stroke Center, Department of Neuroscience, Hospital Clínic of Barcelona, Barcelona, Spain
- Francisco Purroy
- Stroke Unit, Department of Neurology, University Hospital Arnau of Vilanova, Lleida, Spain
- Sergio Amaro
- Comprehensive Stroke Center, Department of Neuroscience, Hospital Clínic of Barcelona, Barcelona, Spain
- Mikel Terceño
- Stroke Unit, Department of Neurology, Josep Trueta University Hospital, Girona, Spain
- Víctor Obach
- Comprehensive Stroke Center, Department of Neuroscience, Hospital Clínic of Barcelona, Barcelona, Spain
- Joaquim Serena
- Stroke Unit, Department of Neurology, Josep Trueta University Hospital, Girona, Spain
- Joan Martí-Fàbregas
- Stroke Unit, Department of Neurology, Santa Creu i Sant Pau, Barcelona, Spain
- Pedro Cardona
- Stroke Unit, Department of Neurology, Bellvitge University Hospital, Barcelona, Spain
- Carlos Molina
- Stroke Unit, Department of Neurology, Vall d'Hebron University Hospital, Barcelona, Spain
- Ana Rodríguez-Campello
- Stroke Unit, Department of Neurology, Hospital del Mar, Barcelona, Spain
- David Cánovas
- Department of Neurology, Parc Taulí Hospital, Sabadell, Spain
- Jerzy Krupinski
- Department of Neurology, Mutua de Terrassa University Hospital, Terrassa, Spain
- Xavier Ustrell
- Stroke Unit, Department of Neurology, Joan XXIII University Hospital, Terragona, Spain
- Ferran Torres
- Medical Statistics Core Facility, August Pi i Sunyer Biomedical Research Institute (IDIBAPS) and Hospital Clinic, Barcelona, Spain
- Luis San Román
- Department of Radiology, Hospital Clínic of Barcelona, Barcelona, Spain
- Mercè Salvat-Plana
- Department of Health, Pla Director Malaltia Vascular Cerebral (Catalan Stroke Program), Barcelona, Spain
- Francesc Xavier Jiménez-Fàbrega
- Emergency Medical Services of Catalonia, Barcelona, Spain
- Ernest Palomeras
- Department of Neurology, Hospital of Mataró, Mataró, Spain
- Esther Catena
- Department of Neurology, Consorci Sanitari Garraf Hospital, Sant Pere de Ribes, Spain
- Carla Colom
- Department of Emergency, Hospital of Igualada, Igualada, Spain
- Dolores Cocho
- Department of Emergency, Hospital of Granollers, Granollers, Spain
- Juanjo Baiges
- Department of Emergency, Verge de la Cinta Hospital, Tortosa, Spain
- Josep Maria Aragones
- Department of Emergency, Vic University Hospital, Vic, Spain
- Gloria Diaz
- Department of Emergency, Hospital of Campdevànol, Campdevànol, Spain
- Xavier Costa
- Department of Emergency, Hospital of Figueres, Figueres, Spain
- María Cruz Almendros
- Department of Emergency, Hospital of Palamós, Palamós, Spain
- Maria Rybyeba
- Department of Emergency, Hospital of Olot, Olot, Spain
- Miquel Barceló
- Department of Emergency, Cerdanya Hospital, Puigcerdá, Spain
- Dolors Carrión
- Department of Emergency, Hospital of Móra d’Ebre, Móra d’Ebre, Spain
- Matilde Núria Lòpez
- Department of Emergency, Seu d’Urgell Hospital, Seu d’Urgell, Spain
- Eduard Sanjurjo
- Department of Emergency, Hospital of Tremp, Tremp, Spain
- Natalia Pérez de la Ossa
- Stroke Unit, Department of Neuroscience, Germans Trias Hospital, Badalona, Spain
- Xabier Urra
- Comprehensive Stroke Center, Department of Neuroscience, Hospital Clínic of Barcelona, Barcelona, Spain
- Ángel Chamorro
- Comprehensive Stroke Center, Department of Neuroscience, Hospital Clínic of Barcelona, Barcelona, Spain
- for the Catalan Stroke Code and Reperfusion (Cat-SCR) Consortium
- DOI
- https://doi.org/10.5853/jos.2021.00962
- Journal volume & issue
-
Vol. 23,
no. 3
pp. 401 – 410
Abstract
Background and Purpose In real-world practice, the benefit of mechanical thrombectomy (MT) is uncertain in stroke patients with very favorable or poor prognostic profiles at baseline. We studied the effectiveness of MT versus medical treatment stratifying by different baseline prognostic factors. Methods Retrospective analysis of 2,588 patients with an ischemic stroke due to large vessel occlusion nested in the population-based registry of stroke code activations in Catalonia from January 2017 to June 2019. The effect of MT on good functional outcome (modified Rankin Score ≤2) and survival at 3 months was studied using inverse probability of treatment weighting (IPTW) analysis in three pre-defined baseline prognostic groups: poor (if pre-stroke disability, age >85 years, National Institutes of Health Stroke Scale [NIHSS] >25, time from onset >6 hours, Alberta Stroke Program Early CT Score 3), good (if NIHSS <6 or distal occlusion, in the absence of poor prognostic factors), or reference (not meeting other groups’ criteria). Results Patients receiving MT (n=1,996, 77%) were younger, had less pre-stroke disability, and received systemic thrombolysis less frequently. These differences were balanced after the IPTW stratified by prognosis. MT was associated with good functional outcome in the reference (odds ratio [OR], 2.9; 95% confidence interval [CI], 2.0 to 4.4), and especially in the poor baseline prognostic stratum (OR, 3.9; 95% CI, 2.6 to 5.9), but not in the good prognostic stratum. MT was associated with survival only in the poor prognostic stratum (OR, 2.6; 95% CI, 2.0 to 3.3). Conclusions Despite their worse overall outcomes, the impact of thrombectomy over medical management was more substantial in patients with poorer baseline prognostic factors than patients with good prognostic factors.
Keywords